首页> 外文期刊>Therapeutic Drug Monitoring >Stereoselective quantification of methadone and a d(6)-labeled isotopomer using high performance liquid chromatography-atmospheric pressure chemical ionization mass-spectrometry: application to a pharmacokinetic study in a methadone maintained subjec
【24h】

Stereoselective quantification of methadone and a d(6)-labeled isotopomer using high performance liquid chromatography-atmospheric pressure chemical ionization mass-spectrometry: application to a pharmacokinetic study in a methadone maintained subjec

机译:使用高效液相色谱-常压化学电离质谱法对美沙酮和d(6)标记的同位素异构体进行立体选择性定量:在美沙酮维持的受试者体内药代动力学研究中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

There is evidence that the apparent oral clearance of rac-methadone is induced during the early phase of methadone maintenance treatment. However, it is not known if this is due to changes in bioavailability or if this phenomenon is stereoselective. This knowledge can be obtained by administering a dose of stable-labeled methadone at selected times during ongoing treatment. Therefore, the authors developed a stereoselective high performance liquid chromatography-atmospheric pressure chemical ionization mass-spectrometry assay for the quantification of the enantiomers of methadone and a d(6)-labeled isotopomer. The compounds were quantified in a single assay after liquid-liquid extraction and stereoselective high performance liquid chromatograph with atmospheric pressure chemical ionization-mass spectrometry detection. The following ions were monitored: m/z 310.15 for unlabeled methadone; m/z 316.15 for methadone-d(6); and m/z 313.15 for the methadone-d(3) (internal standard). Calibration curves ranged from 0.5 to 75 ng/mL for each compound. Extraction recovery was approximately 80% for all analytes, without evidence of differences between the unlabeled and stable-labeled compounds or concentration dependency. Minor ion promotion was observed (<15%) but this was identical for all analytes including the d(3)-labeled internal standard, with peak area ratios in extracted samples identical to control injections. The isotopomers did not alter each others' ionisation, even at 10:1 concentration ratios, and 10-fold diluted samples were within 10% of the nominal concentration. Assay performance was acceptable, with interassay and intra-assay bias and precision <10% for all compounds, including the upper and lower limits of quantitation. In conclusion, the assay was successfully applied to quantify the concentration of the methadone enantiomers of both orally administered unlabeled methadone and an intravenous 5 mg dose of methadone-d(6) in a patient receiving chronic oral methadone maintenance therapy.
机译:有证据表明,在美沙酮维持治疗的早期阶段,诱导了rac-美沙酮的明显口腔清除率。但是,尚不知道这是由于生物利用度的变化还是该现象是立体选择性的。通过在持续治疗期间的选定时间施用一定剂量的稳定标记的美沙酮,可以获得这些知识。因此,作者开发了一种立体选择性高效液相色谱-常压化学电离质谱分析法,用于定量美沙酮和d(6)标记的同位素异构体的对映异构体。在液-液萃取和具有大气压化学电离质谱检测的立体选择性高效液相色谱仪后,通过一次测定对化合物进行定量。监测以下离子:m / z 310.15中未标记的美沙酮;美沙酮-d(6)的m / z 316.15;美沙酮-d(3)(内标)的m / z 313.15。每种化合物的校准曲线范围为0.5至75 ng / mL。所有分析物的提取回收率约为80%,没有证据表明未标记和稳定标记的化合物之间存在差异或浓度依赖性。观察到较小的离子促进作用(<15%),但这对于包括d(3)标记的内标物在内的所有分析物都是相同的,提取样品中的峰面积比与对照进样相同。即使在10:1的浓度比下,同位素异构体也不会改变彼此的电离,并且10倍稀释的样品在标称浓度的10%以内。测定性能是可以接受的,所有化合物(包括定量上限和下限)的批间和批内偏倚和精密度<10%。总之,在接受慢性口服美沙酮维持治疗的患者中,该测定法成功地用于定量口服未标记美沙酮和静脉内5 mg剂量美沙酮-d(6)的美沙酮对映体浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号